MALE GENITAL SYSTEM PENIS SCROTUM, TESTIS, & EPIDIDYMIS PROSTATE KUMAR, COTRAN, AND ROBBINS 7 th...
-
Upload
britton-ellis -
Category
Documents
-
view
224 -
download
3
Transcript of MALE GENITAL SYSTEM PENIS SCROTUM, TESTIS, & EPIDIDYMIS PROSTATE KUMAR, COTRAN, AND ROBBINS 7 th...
MALE GENITAL SYSTEM
• PENIS
• SCROTUM, TESTIS, & EPIDIDYMIS
• PROSTATE
KUMAR, COTRAN, AND ROBBINS
7th Edition
CH 18
PENIS
• MALFORMATIONS
• INFLAMMATORY LESIONS
• NEOPLASMS
MALFORMATIONS OF THE PENIS
ABNORMAL LOCATION OF URETHRAL ORIFICE ALONG PENILE SHAFT– HYPOSPADIAS (VENTRAL ASPECT)
• MOST COMMON (1/300 LIVE MALE BIRTHS)
– EPISPADIAS (DORSAL ASPECT)
Hypospadias
Epispadias
– MAY BE ASSOCIATED WITH OTHER GENITAL ABNORMALITIES• INGUINAL HERNIAS• UNDESCENDED TESTES
– CLINICAL CONSEQUENCES• CONSTRICTION OF ORIFICE• URINARY TRACT OBSTRUCTION• URINARY TRACT INFECTION• IMPAIRED REPRODUCTIVE FUNCTION
HYPOSPADIAS AND EPISPADIAS
INFLAMMATORY LESIONS OF THE PENIS
• SEXUALLY TRANSMITTED DISEASES• BALANITIS (BALANOPOSTHITIS)
– INFLAMMATION OF THE GLANS (PLUS PREPUCE)
– ASSOCIATED WITH POOR LOCAL HYGIENE IN UNCIRCUMCISED MEN
• SMEGMA
– DISTAL PENIS IS RED, SWOLLEN, TENDER• +/- PURULENT DISCHARGE
• PHIMOSIS– PREPUCE CANNOT BE EASILY
RETRACTED OVER GLANS– MAY BE CONGENITAL– USUALLY ASSOCIATED WITH
BALANOPOSTHITIS AND SCARRING– PARAPHIMOSIS (TRAPPED GLANS)
• URETHRAL CONSTRICTION
INFLAMMATORY LESIONS OF THE PENIS
• FUNGAL INFECTIONS– CANDIDIASIS
• ESPECIALLY IN DIABETICS
• EROSIVE, PAINFUL, PRURITIC
• CAN INVOLVE ENTIRE MALE EXTERNAL GENITALIA
INFLAMMATORY LESIONS OF THE PENIS
NEOPLASMS OF THE PENIS
• SQUAMOUS CELL CARCINOMA (SCC)– EPIDEMIOLOGY
• UNCOMMON – LESS THAN 1 % OF CA IN US MEN• UNCIRCUMCISED MEN BETWEEN 40 AND 70
– PATHOGENESIS• POOR HYGIENE, SMEGMA• HUMAN PAPILLOMA VIRUS (16 AND 18)• CIS FIRST, THEN PROGRESSION TO INVASIVE
SQUAMOUS CELL CARCINOMA
Squamous Cell Carcinoma
• CLINICAL COURSE– USUALLY INDOLENT– LOCALLY INVASIVE– HAS SPREAD TO INGUINAL LYMPH NODES
IN 25% OF CASES AT PRESENTATION– DISTANT METS RARE– 5 YR SURVIVAL
• 70% WITHOUT LN METS• 27% WITH LN METS
SCC OF THE PENIS
LESIONS INVOLVING THE SCROTUM
• INFLAMMATION– TINEA CRURIS (JOCK ITCH)
• SUPERFICIAL DERMATOPHYTE INFECTION• SCALY, RED, ANNULAR PLAQUES, PRURITIC• INGUINAL CREASE TO UPPER THIGH
• SQUAMOUS CELL CARCINOMA– HISTORICAL SIGNIFICANCE– SIR PERCIVAL POTT, 18TH CENTURY
ENGLISH PHYSICIAN– CHIMNEY SWEEPS
• SCROTAL ENLARGEMENT– HYDROCELE - MOST COMMON CAUSE
• ACCUMULATION OF SEROUS FLUID WITHIN TUNICA VAGINALIS
• INFECTIONS, TUMOR, IDIOPATHIC
– HEMATOCELE– CHYLOCELE
• FILIARIASIS - ELEPHANTIASIS
– TESTICULAR DISEASE
LESIONS INVOLVING THE SCROTUM
Hydrocele
LESIONS OF THE TESTES
• CONGENITAL
• INFLAMMATORY
• NEOPLASTIC
CRYPTORCHIDISM AND TESTICULAR ATROPHY
• FAILURE OF TESTICULAR DESCENT• EPIDEMIOLOGY
– ABOUT 1% OF MALES– RIGHT > LEFT, 25% BILATERAL
• PATHOGENESIS– HORMONAL ABNORMALITIES– TESTICULAR ABNORMALITIES– MECHANICAL PROBLEMS
Atrophic testes secondary to cryporchidism
• CLINICAL COURSE– WHEN UNILATERAL, MAY SEE ATROPHY IN
CONTRALATERAL TESTIS– STERILITY– INCREASED RISK OF MALIGNANCY (4-10X)– ORCHIOPEXY
• MAY HELP PREVENT ATROPHY
• MAY NOT DECREASE RISK OF MALIGNANCY
CRYPTORCHIDISM AND TESTICULAR ATROPHY
OTHER CAUSES OF TESTICULAR ATROPHY
• CHRONIC ISCHEMIA• INFLAMMATION OR TRAUMA• HYPOPITUITARISM• EXCESS FEMALE SEX HORMONES
– THERAPEUTIC ADMINISTRATION– CIRRHOSIS
• MALNUTRITION• IRRADIATION• CHEMOTHERAPY
INFLAMMATORY LESIONS OF THE TESTIS
• USUALLY INVOLVE THE EPIDIDYMIS FIRST
• SEXUALLY TRANSMITTED DISEASES
• NONSPECIFIC EPIDIDYMITIS AND ORCHITIS– SECONDARY TO UTI
• BACTERIAL AND NON-BACTERIAL
– SWELLING, TENDERNESS– ACUTE INFLAMMATORY INFILTRATE
• MUMPS– 20% OF ADULT MALES WITH MUMPS– EDEMA AND CONGESTION– CHRONIC INFLAMMATORY INFILTRATE– MAY CAUSE ATROPHY AND STERILITY
• TUBERCULOSIS– GRANULOMATOUS INFLAMMATION– CASEOUS NECROSIS
• AUTOIMMUNE GRANULOMATOUS ORCHITIS– RARE FINDING IN MIDDLE AGED MEN
INFLAMMATORY LESIONS OF THE TESTIS
TESTICULAR NEOPLASMS• EPIDEMIOLOGY
– MOST IMPORTANT CAUSE OF PAINLESS ENLARGEMENT OF TESTIS
– 2/100,000 MALES, WHITES > BLACKS (US)– INCREASED FREQUENCY IN SIBLINGS– PEAK INCIDENCE 15-34 YRS– MOST ARE MALIGNANT– ASSOCIATED WITH GERM CELL
MALDEVELOPMENT• CRYPTORCHIDISM• TESTICULAR DYSGENESIS(XXY)
• PATHOGENESIS– 95% ARISE FROM GERM CELLS
• ISOCHROMOSOME 12, i(12p), IS A COMMON FINDING
• INTRATUBULAR GERM CELL NEOPLASMS
– RARELY ARISE FROM SERTOLI CELLS OR LEYDIG CELLS
• THESE ARE OFTEN BENIGN
– Lymphoma• men > 60 yo
TESTICULAR NEOPLASMS
WHO CLASSIFICATION OF TESTICULAR TUMORS
• ONE HISTOLOGIC PATTERN (40%)– SEMINOMAS (30%)– EMBRYONAL CARCINOMA– YOLK SAC TUMOR– CHORIOCARCINOMA– TERATOMA
• MULTIPLE HISTOLOGIC PATTERNS (60%)– EMBRYONAL CA + TERATOMA– CHORIOCARCINOMA + OTHER– OTHER COMBINATIONS
HISTOGENESIS OF TESTICULAR NEOPLASMS (PEAK INCIDENCE)
GERM CELL PRECURSOR
SEMINOMA(40-50 Y)
GONADALDIFFERENTIATION
EMBRYONAL CA(UNDIFFERENTIATED)
(20-30 Y)
TOTIPOTENTIALDIFFERENTIATION(NONSEMINOMA)
CHORIOCARCINOMA(20-30 Y)
hCG +
TROPHOBLASTICDIFFERENTIATION
YOLK SAC TUMOR(< 3 Y)AFP +
YOLK SACDIFF
TERATOMA(ALL AGES)
MATURE
IMMATURE
MALIGNANT TX
SOMATICDIFFERENTIATION
Seminoma, with focal hemorrhage and necrosis
Normal testicular tissue
Seminoma
Seminoma
Syncytiotrophoblast
Dermoid Cyst
Immature Teratoma
With Embryonal Carcinoma
CLINICAL COURSE OF TESTICULAR TUMORS
• USUALLY PRESENT WITH PAINLESS ENLARGEMENT OF TESTIS
• MAY PRESENT WITH METASTASES– NONSEMINOMAS (MORE COMMON)
• LYMPH NODES, LIVER AND LUNGS
– SEMINOMAS• USUALLY JUST REGIONAL LYMPH NODES
• TUMOR MARKERS (hCG AND AFP)• TREATMENT SUCCESS DEPENDS ON HISTOLOGY
AND STAGE– SEMINOMAS VERY SENSITIVE TO BOTH RADIO- AND
CHEMOTHERAPY
DISEASES OF THE PROSTATE
• PROSTATITIS
• NODULAR HYPERPLASIA
• CANCER
PROSTATITIS
• ACUTE BACTERIAL PROSTATITIS
• CHRONIC BACTERIAL PROSTATITIS
• CHRONIC ABACTERIAL PROSTATITIS
ACUTE BACTERIAL PROSTATITIS
• ETIOLOGY– SAME ORGANISMS THAT CAUSE UTI
• E coli, OTHER GNR
• PATHOGENESIS– ORGANISMS ASCEND FROM URETHRA
AND URINARY BLADDER– RARELY, HEMATOGENOUS SPREAD
• MORPHOLOGY– ACUTE INFLAMMATION, ESPECIALLY IN THE
GLANDS, WITH MICROABSESSES– CONGESTION, EDEMA
• CLINICAL COURSE– DYSURIA, FREQUENCY, LOW BACK PAIN,
PELVIC PAIN– ENLARGED, EXQUISITELY TENDER– +/- FEVER OR LEUKOCYTOSIS– USUALLY RESOLVES WITH WITH AB RX
ACUTE BACTERIAL PROSTATITIS
CHRONIC PROSTATITIS
• ETIOLOGY– MAY FOLLOW ACUTE PROSTATITIS– MAY DEVELOP INSIDIOUSLY– CULTURE POSITIVE (BACTERIAL)
• SAME ORGANISMS THAT CAUSE AP
– CULTURE NEGATIVE (ABACTERIAL)• MAY BE RELATED TO
– CHLAMYDIA TRACHOMATIS– UREAPLASMA UREALYTICUM
• MOST COMMON FORM OF CP
• MORPHOLOGY– LYMPHOCYTIC INFILTRATE– NEUTROPHILS AND MACROPHAGES– SOME EVIDENCE OF TISSUE DESTRUCTION
• CLINICAL COURSE– SIMILAR TO AP
• LESS ACUTE SYMPTOMS• MORE RESISTANT TO AB RX
– CBP OFTEN ASSOCIATED WITH RECURRENT UTI
CHRONIC PROSTATITIS
PROLIFERATIVE LESIONS OF THE PROSTATE
URETHRAPERIURETHRAL AND TRANSITIONAL ZONES PERIPHERAL
ZONE
NORMAL PROSTATE
NODULAR HYPERPLASIA CARCINOMA
NODULAR HYPERPLASIA
• OTHER TERMS USED– GLANDULAR AND STROMAL
HYPERPLASIA– BENIGN PROSTATIC HYPERTROPHY
(HYPERPLASIA)
• EPIDEMIOLOGY– OCCURS IN 20% OF MEN OVER 40– OCCURS IN 90% OF MEN OVER 70
• PROLIFERATION OF BOTH EPITHELIAL AND STROMAL ELEMENTS
• BOTH ANDROGENS AND ESTROGENS MAY PLAY A ROLE– NOT SEEN IN MALES CASTRATED BEFORE
PUBERTY– INHIBITORS OF TESTOSTERONE METABOLISM
USEFUL IN TREATMENT– RELATIVE INCREASE IN ESTROGENS IN OLDER
MEN MAY INCREASE DHT RECEPTORS IN PROSTATE
PATHOGENESIS OF NODULAR HYPERPLASIA
CLINICAL COURSE OF NODULAR HYPERPLASIA
• SYMPTOMS OCCUR IN ONLY 10% OF MEN WITH NODULAR HYPERPLASIA
• HESITANCY• URINARY RETENTION
– URGENCY, FREQUENCY, NOCTURIA, UTI
• TREATMENT– MEDICAL– SURGICAL
• COMMON CAUSE FOR ELEVATED PROSTATE SPECIFIC ANTIGEN (PSA)
CARCINOMA OF THE PROSTATE
• EPIDEMIOLOGY– MOST COMMON VISCERAL CANCER
• ABOUT 70/100,000 MEN IN US• 200,000 NEW CASES/YR IN US• 20% ARE LETHAL
– SECOND MOST COMMON CAUSE OF CANCER DEATH IN MEN
– PEAK INCIDENCE OF CLINICAL CANCER IS 65-75 YO
– LATENT CA IS EVEN MORE PREVALENT• >50% IN MEN > 80 YO
• PATHOGENESIS– HORMONAL FACTORS
• DOES NOT OCCUR IN EUNUCHS• ORCHIECTOMY AND/OR ESTROGEN TREATMENT
INHIBITS GROWTH
– GENETIC FACTORS• INCREASED RISK IN FIRST ORDER RELATIVES• BLACKS > WHITES (SYMPTOMATIC CA)
– ENVIRONMENTAL FACTORS• GEOGRAPHIC DIFFERENCES IN INCIDENCE OF
CLINICAL CANCER (NOT OF LATENT CA)• CHANGE IN INCIDENCE WITH MIGRATION
CARCINOMA OF THE PROSTATE
• CLINICAL COURSE– OFTEN CLINICALLY SILENT– DIGITAL RECTAL EXAM (DRE)– PROSTATE SPECIFIC ANTIGEN (PSA)
• > 4 ng/ml IN PERIPHERAL BLOOD• FREE PSA < 25%
– TRANSRECTAL ULTRASOUND– NEEDLE BIOPSY– PROSTATISM (LIKE BPH)– METASTASES
• OSTEOBLASTIC
– TREATMENT- SURGERY, RADIATION, HORMONES, CHEMO
CARCINOMA OF THE PROSTATE
Needle bx of prostate
• STAGINGA (T1) MICROSCOPIC ONLY
B(T2) MACROSCOPIC (PALPABLE)
C(T3 &T4) EXTRACAPSULAR
D(N1-3,M1) METASTATIC
• PROGNOSIS DEPENDENT ON STAGE AND HISTOLOGIC GRADE– 90% 10 YR SURVIVAL FOR A AND B
– 10-40% 10 YR SURVIVAL FOR C AND D
CARCINOMA OF THE PROSTATE
Hydronephrosis